Allergic Rhinitis
Conditions
Interventions
Experimental group:Jingui Shenqi Wan Decoction combined with Western medicine
Sponsors
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for allergic rhinitis (2022 Chinese guidelines); 2. Traditional Chinese medicine syndrome differentiation is kidney yang deficiency type, and the total symptom score is = 10 points; 3. Age 18-65 years old, gender is not limited; 4. Subjects must understand the purpose of the study, voluntarily participate, and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women. 2. Those who have used antihistamines (such as loratadine, ebastine, etc.) within 1 week. 3. Those who use sodium perchromoglycate and leukotriene receptor antagonists within 2 weeks. 4. Those who have received biological agent treatment within 6 months. 5. Those who have received allergen-specific immunotherapy (desensitization therapy) within 5 years. 6. Those who have undergone major surgery within 4 weeks. 7. Those who have used systemic glucocorticoids (oral, intravenous, etc.) within 4 weeks. 8. Those who have alcohol abuse or abuse of illicit drugs currently or in the past 3 years. 9. Those who have recently used nasal glucocorticoids or nasal decongestants (within 2-4 weeks). 10. Those who have any active, acute or chronic nasal or pulmonary disease (including asthma) confirmed by medical history or physical examination. 11. Those who lack cooperation or understanding ability to complete the questionnaire.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) for nasal symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Rhinoconjunctivitis Quality of Life Questionnaire (mRQLQ);Traditional Chinese Medicine (TCM) Syndrome Score;Nasal Resistance;Acoustic Rhinometry;Nasal Patency Value (Peak Nasal Inspiratory Flow, PNIF);Overall Response Rate;Relapse Rate; | — |
Countries
China
Contacts
Public ContactLi Xinrong
The Affiliated Hospital of Chengdu University of Traditional Chinese Medicin
Outcome results
None listed